Free Trial

Glaukos (GKOS) Competitors

Glaukos logo
$88.01 -0.48 (-0.54%)
Closing price 08/7/2025 03:59 PM Eastern
Extended Trading
$88.00 -0.01 (-0.01%)
As of 07:15 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GKOS vs. ZBH, SNN, SOLV, PEN, STVN, IRTC, BLCO, TMDX, SLNO, and INSP

Should you be buying Glaukos stock or one of its competitors? The main competitors of Glaukos include Zimmer Biomet (ZBH), Smith & Nephew SNATS (SNN), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), and Inspire Medical Systems (INSP). These companies are all part of the "medical equipment" industry.

Glaukos vs. Its Competitors

Zimmer Biomet (NYSE:ZBH) and Glaukos (NYSE:GKOS) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation, profitability and media sentiment.

88.9% of Zimmer Biomet shares are owned by institutional investors. Comparatively, 99.0% of Glaukos shares are owned by institutional investors. 1.4% of Zimmer Biomet shares are owned by insiders. Comparatively, 5.8% of Glaukos shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Zimmer Biomet has higher revenue and earnings than Glaukos. Glaukos is trading at a lower price-to-earnings ratio than Zimmer Biomet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Zimmer Biomet$7.68B2.53$903.70M$4.5221.75
Glaukos$383.48M13.16-$146.37M-$1.65-53.34

Zimmer Biomet presently has a consensus target price of $111.65, suggesting a potential upside of 13.57%. Glaukos has a consensus target price of $127.42, suggesting a potential upside of 44.78%. Given Glaukos' stronger consensus rating and higher possible upside, analysts clearly believe Glaukos is more favorable than Zimmer Biomet.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Zimmer Biomet
1 Sell rating(s)
9 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.42
Glaukos
1 Sell rating(s)
1 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.85

In the previous week, Zimmer Biomet had 10 more articles in the media than Glaukos. MarketBeat recorded 22 mentions for Zimmer Biomet and 12 mentions for Glaukos. Zimmer Biomet's average media sentiment score of 1.17 beat Glaukos' score of 0.63 indicating that Zimmer Biomet is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Zimmer Biomet
18 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Glaukos
4 Very Positive mention(s)
3 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Zimmer Biomet has a net margin of 11.86% compared to Glaukos' net margin of -21.43%. Zimmer Biomet's return on equity of 12.73% beat Glaukos' return on equity.

Company Net Margins Return on Equity Return on Assets
Zimmer Biomet11.86% 12.73% 7.34%
Glaukos -21.43%-8.59%-6.61%

Zimmer Biomet has a beta of 0.68, suggesting that its stock price is 32% less volatile than the S&P 500. Comparatively, Glaukos has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500.

Summary

Zimmer Biomet beats Glaukos on 9 of the 17 factors compared between the two stocks.

Get Glaukos News Delivered to You Automatically

Sign up to receive the latest news and ratings for GKOS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GKOS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GKOS vs. The Competition

MetricGlaukosMED INSTRUMENTS IndustryMedical SectorNYSE Exchange
Market Cap$5.07B$6.80B$5.48B$20.71B
Dividend YieldN/A1.35%3.99%3.67%
P/E Ratio-53.3424.4429.9428.65
Price / Sales13.1654.22398.9469.00
Price / CashN/A20.5535.9423.59
Price / Book6.605.528.104.32
Net Income-$146.37M$178.18M$3.26B$995.66M
7 Day Performance1.87%-0.57%0.68%1.91%
1 Month Performance-14.19%-5.36%2.46%-0.54%
1 Year Performance-26.94%6.18%27.69%14.76%

Glaukos Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GKOS
Glaukos
4.0015 of 5 stars
$88.01
-0.5%
$127.42
+44.8%
-24.1%$5.07B$383.48M-53.34780
ZBH
Zimmer Biomet
4.6624 of 5 stars
$92.48
+2.0%
$111.39
+20.5%
-7.1%$18.30B$7.68B20.4617,000Positive News
Earnings Report
Analyst Forecast
Gap Up
SNN
Smith & Nephew SNATS
2.4299 of 5 stars
$30.79
-0.1%
$28.00
-9.1%
+21.3%$13.49B$5.81B14.2617,349Dividend Cut
Gap Up
SOLV
Solventum
1.4575 of 5 stars
$73.24
+2.1%
$84.38
+15.2%
+28.8%$12.67B$8.31B33.9122,000News Coverage
Positive News
Earnings Report
PEN
Penumbra
4.882 of 5 stars
$240.71
-0.9%
$300.47
+24.8%
+46.7%$9.39B$1.19B64.024,500
STVN
Stevanato Group
2.1493 of 5 stars
€25.58
+1.8%
N/A+23.3%€7.75B€1.19B50.165,521News Coverage
Analyst Revision
IRTC
iRhythm Technologies
1.8142 of 5 stars
$164.98
+0.0%
$157.30
-4.7%
+135.0%$5.30B$591.84M-56.312,000Insider Trade
BLCO
Bausch + Lomb
3.1004 of 5 stars
$13.76
+1.9%
$15.56
+13.0%
-10.0%$4.87B$4.89B-17.6413,500
TMDX
TransMedics Group
2.6411 of 5 stars
$128.50
+6.6%
$123.00
-4.3%
-20.4%$4.38B$531.29M66.58210
SLNO
Soleno Therapeutics
4.5817 of 5 stars
$84.12
-2.2%
$108.70
+29.2%
+79.0%$4.24BN/A-18.2130Earnings Report
Analyst Forecast
Gap Up
INSP
Inspire Medical Systems
4.64 of 5 stars
$130.79
+3.7%
$208.55
+59.5%
-59.1%$3.86B$840.11M60.271,246Trending News
Earnings Report
Analyst Forecast
Analyst Revision
High Trading Volume

Related Companies and Tools


This page (NYSE:GKOS) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners